Basic Information
RebrAIn is a company headquartered in France, dedicated to providing precise targeting for DBS and lesion treatments in patients with severe Parkinson's disease or organic tremor. Its SaaS solution assists neurosurgeons in accurately identifying the target areas for surgical intervention. Its innovative approach utilizes machine learning from clinical patient data to predict the optimal treatment regions in each patient’s brain.
RebrAIn SAS
France
less than 15 people
January 01, 2021
contact@rebrain.eu

